Physician profile
John Arnold
NPI 1659894921
$3,993.40
in general payments reported to CMS, 2019-2025
19 companies · $1,927 in 2025
The $1,927 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $514 · 2023: $578 · 2024: $561 · 2025: $1,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,213 · Travel and Lodging: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.16 |
| Travel and Lodging | $852.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,321.93 | 2021-2025 | Watchman, Watchman Access System, General - Therapies |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $580.69 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $577.45 | 2022-2025 | |
| Amgen INC. | $404.30 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $219.43 | 2022-2025 | Farxiga |
| Pfizer INC. | $186.31 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $168.80 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.99 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $75.63 | 2021-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $61.40 | 2021-2023 | Xarelto |
| Esperion Therapeutics, INC. | $56.06 | 2021 | |
| Merck Sharp & Dohme LLC | $50.08 | 2023 | Verquvo |
| Smith+Nephew, INC. | $34.69 | 2025 | Renasys Go V2 Home |
| Ethicon US, LLC | $31.70 | 2025 | Surgicel Nu-Knit, Prolene, Vistaseal |
| Kestra Medical Technology Services, INC. | $22.69 | 2025 | Assure Wcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $18.72 | 2022 | |
| Atricure, INC. | $17.73 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kiniksa Pharmaceuticals International, Plc | $17.42 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $16.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.